| Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease S Salloway, R Sperling, NC Fox, K Blennow, W Klunk, M Raskind, ... New England Journal of Medicine 370 (4), 322-333, 2014 | 2182 | 2014 |
| Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease RS Doody, RG Thomas, M Farlow, T Iwatsubo, B Vellas, S Joffe, ... New England Journal of Medicine 370 (4), 311-321, 2014 | 1840 | 2014 |
| Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints … S Andrieu, S Guyonnet, N Coley, C Cantet, M Bonnefoy, S Bordes, ... The Lancet Neurology 16 (5), 377-389, 2017 | 809 | 2017 |
| APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases HM Lanoiselée, G Nicolas, D Wallon, A Rovelet-Lecrux, M Lacour, ... PLoS medicine 14 (3), e1002270, 2017 | 570 | 2017 |
| A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ... Nature medicine 26 (3), 398-407, 2020 | 506 | 2020 |
| A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas S Assou, T Le Carrour, S Tondeur, S Ström, A Gabelle, S Marty, L Nadal, ... Stem cells 25 (4), 961-973, 2007 | 416 | 2007 |
| MAPT study: a multidomain approach for preventing Alzheimer’s disease: design and baseline data B Vellas, I Carrie, S Gillette-Guyonnet, J Touchon, T Dantoine, ... The journal of prevention of Alzheimer's disease 1 (1), 13, 2014 | 305 | 2014 |
| High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease C Pottier, D Hannequin, S Coutant, A Rovelet-Lecrux, D Wallon, ... Molecular psychiatry 17 (9), 875-879, 2012 | 304 | 2012 |
| Cerebrospinal fluid amyloid β40 is decreased in cerebral amyloid angiopathy MM Verbeek, BPH Kremer, MO Rikkert, PHMF Van Domburg, ME Skehan, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 228 | 2009 |
| Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification NR Barthélemy, RJ Bateman, C Hirtz, P Marin, F Becher, C Sato, ... Alzheimer's research & therapy 12, 1-11, 2020 | 208 | 2020 |
| SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis I Le Ber, A Camuzat, R Guerreiro, K Bouya-Ahmed, J Bras, G Nicolas, ... JAMA neurology 70 (11), 1403-1410, 2013 | 204 | 2013 |
| TREM2 R47H Variant as a Risk Factor for Early-Onset Alzheimer's Disease C Pottier, D Wallon, S Rousseau, A Rovelet-Lecrux, AC Richard, ... Journal of Alzheimer’s Disease 35 (1), 45-49, 2013 | 180 | 2013 |
| C9orf72 repeat expansions are a rare genetic cause of parkinsonism S Lesage, I Le Ber, C Condroyer, E Broussolle, A Gabelle, S Thobois, ... Brain 136 (2), 385-391, 2013 | 179 | 2013 |
| Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study J Dumurgier, S Schraen, A Gabelle, O Vercruysse, S Bombois, ... Alzheimer's research & therapy 7, 1-9, 2015 | 158 | 2015 |
| Memantine in behavioral variant frontotemporal dementia: negative results M Vercelletto, C Boutoleau-Bretonnière, C Volteau, M Puel, S Auriacombe, ... Journal of Alzheimer's disease 23 (4), 749-759, 2011 | 153 | 2011 |
| Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers O Hanon, JS Vidal, S Lehmann, S Bombois, B Allinquant, JM Tréluyer, ... Alzheimer's & Dementia 14 (7), 858-868, 2018 | 142 | 2018 |
| SORL1 rare variants: a major risk factor for familial early-onset Alzheimer’s disease G Nicolas, C Charbonnier, D Wallon, O Quenez, C Bellenguez, ... Molecular psychiatry 21 (6), 831-836, 2016 | 141 | 2016 |
| Differential mass spectrometry profiles of tau protein in the cerebrospinal fluid of patients with Alzheimer’s disease, progressive supranuclear palsy, and dementia with lewy … NR Barthélemy, A Gabelle, C Hirtz, F Fenaille, N Sergeant, ... Journal of Alzheimer's Disease 51 (4), 1033-1043, 2016 | 139 | 2016 |
| The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkers D Wallon, S Rousseau, A Rovelet-Lecrux, M Quillard-Muraine, ... Journal of Alzheimer’s disease 30 (4), 847-856, 2012 | 137 | 2012 |
| Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of … S Gillette-Guyonnet, S Andrieu, T Dantoine, JF Dartigues, J Touchon, ... Alzheimer's & Dementia 5 (2), 114-121, 2009 | 130 | 2009 |
